PT-141 is also known as bremelanotide. It is a synthetic peptide that is being investigated as a treatment for a variety of sexual dysfunctions. It is a melanocortin receptor agonist, meaning that it binds to and activates melanocortin receptors in the brain. Melanocortin receptors are involved in a variety of physiological functions, including appetite, energy metabolism, and sexual behavior.
PT-141 is thought to work by stimulating the release of dopamine and nitric oxide in the brain. Dopamine is a neurotransmitter that plays a role in motivation, reward, and sexual pleasure. Nitric oxide is a vasodilator, meaning that it widens blood vessels. This can increase blood flow to the genitals, which can lead to improved sexual function.
PT-141 is still in the early stages of development, but it has shown promise in clinical trials for the treatment of female hypoactive sexual desire disorder (HSDD), erectile dysfunction (ED) in men, and premature ejaculation (PE) in men.
Other names for PT-141 include:
- Bremelanotide acetate
- Melanotan II
- Melanocortin 4 receptor agonist
- MC4R agonist
- PT-141
- PT-141 peptide
- PT141
- PT141 peptide
- Vyleesi
If you are interested in learning more about PT-141, talk to your doctor. They can help you determine if PT-141 is right for you and can monitor you for any side effects.
